Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas

Carcinogenesis

Volumn 29, Issue 10, 2008, Pages 1901-1910

  Gao, Wentao ^a,b   Kondo, Yutaka ^a   Shen, Lanlan ^c   Shimizu, Yasuhiro ^c   Sano, Tsuyoshi ^a   Yamao, Kenji ^a   Natsume, Atsushi ^d   Goto, Yasuhiro ^a   Ito, Motokazu ^a   Murakami, Hideki ^a   Osada, Hirotaka ^a   Zhang, Jiexin ^c   Issa, Jean Pierre J ^c   Sekido, Yoshitaka ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NANJING MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS   (United States)

^d NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; GENOMIC DNA; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA14 SUBUNIT; MATRIX METALLOPROTEINASE 14; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARCINOGENESIS; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; DISEASE COURSE; DNA METHYLATION; DNA MICROARRAY; FEMALE; GENE AMPLIFICATION; GENE IDENTIFICATION; GENETIC CORRELATION; GENETIC EPIGENESIS; GENOME ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PRIORITY JOURNAL; PYROSEQUENCING; QUANTITATIVE ANALYSIS; TUMOR DIFFERENTIATION;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CPG ISLANDS; DISEASE PROGRESSION; DNA METHYLATION; EPIGENESIS, GENETIC; GENE REGULATORY NETWORKS; HUMANS; LIVER NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; WNT PROTEINS;

EID: 53349171172     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgn170     Document Type: Article

References (47)

1. Thorgeirsson, S.S. et al. (2002) Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet., 31, 339-346.
2. Lencioni,R. et al. (1994) Long-term follow-up study of adenomatous hyperplasia in liver cirrhosis. Ital. J. Gastroenterol., 26, 163-168.
3. Murakami,Y. et al. (1991) Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas. Cancer Res., 51, 5520-5525.
4. Kanai,Y. et al. (2000) Aberrant DNA tnethylation precedes loss of heterozygosity on chromosome 16 in chronic hepatitis and liver cirrhosis. Cancer Lett., 148, 73-80.
5. Kondo,Y. et al. (2000) Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis - A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma. Hepatology, 32, 970-979.
6. Baylin,S.B. et al. (1998) Alterations in DNA methylation: A fundamental aspect of neoplasia. Adv. Cancer Res., 72, 141-196.
7. Jones,P.A. et al. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3, 415-428.
8. Kaneto,H. et al. (2001) Detection of hypermethylation of the p16(INK4A) gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus. Gut, 48, 372-377.
9. Lee,S. et al. (2003) Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Am. J. Pathol., 163, 1371-1378.
10. Costello,J.F. et al. (2000) Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat. Genet., 24 132-138.
11. Estecio,M.R. et al. (2007) High-throughput methylation profiling by MCA coupled to CpG island microarray. Genome Res., 17, 1529-1536.
12. Shen,L. et al. (2007) Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. PLoS Genet., 3, 2023-2036.
13. Toyota,M. et al. (1999) Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res., 59, 2307-2312.
14. Takai,D. et al. (2002) Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc. Natl Acad. Sci. USA, 99, 3740-3745.
15. Eisen,M.B. et al. (1998) Cluster analysis and display of genome-wide expression patterns. Proc. Natl Acad. Sci. USA, 95 14863-14868.
16. Ekins,S. et al. (2007) Pathway mapping tools for analysis of high content data. Methods Mol. Biol., 356, 319-350.
17. Kondo,Y. et al. (2007) Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas. Hepatol. Res., 37, 974-983.
18. Yang,A.S. et al. (2004) A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res., 32, e38.
19. Colella,S. et al. (2003) Sensitive and quantitative universal pyrosequencing methylation analysis of CpG sites. Biotechniques, 35, 146-150.
20. Shen,L. et al. (2007) Optimizing annealing temperature overcomes bias in bisulfite PCR methylation analysis. Biotechniques, 42, 48, 50, 52 passim.
21. Li,B. et al. (2007) The role of chromatin during transcription. Cell, 128, 707-719.
22. Heintzman,N.D. et al. (2007) Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet., 39, 311-318.
23. Lin,J.C. et al. (2007) Role of nucleosomal occupancy in the epigenetic silencing of the MLH1 CpG island. Cancer Cell, 12 432-444.
24. Lin,C.H. et al. (2001) Genome-wide hypomethylation in hepatocellular carcinogenesis. Cancer Res., 61, 4238-4243.
25. Cameron,E.E. et al. (1999) Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat. Genet., 21, 103-107.
26. Weber,M. et al. (2005) Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat. Genet., 37, 853-862.
27. Issa,J.P. (2004) CpG island methylator phenotype in cancer. Nat. Rev. Cancer, 4, 988-993.
28. Zhong,S. et al. (2002) Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas. Clin. Cancer Res., 8, 1087-1092.
29. Park,I.Y. et al. (2007) Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology, 132, 1476-1494.
30. Eads,C.A. et al. (1999) CpG island hypermethylation in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res., 59, 2302-2306.
31. Baylin,S.B. et al. (2006) Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat. Rev. Cancer, 6, 107-116.
32. Ohm,J.E. et al. (2007) A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat. Genet., 39, 237-242.
33. Widschwendter,M. et al. (2007) Epigenetic stem cell signature in cancer. Nat. Genet., 39, 157-158.
34. Lee,J.S. et al. (2006) A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat. Med., 12, 410-416.
35. Feltus,F.A. et al. (2003) Predicting aberrant CpG island methylation. Proc. Natl Acad. Sci. USA, 100, 12253-12258.
36. Myöhänen,S.K. et al. (1998) Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia. Cancer Res., 58, 591-593.
37. Saito,Y. et al. (2006) Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell, 9, 435-443.
38. He,L. et al. (1998) RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis. Cancer Res., 58, 4238-4244.
39. Hoppler,S. et al. (2007) Wnt signalling: Variety at the core. J. Cell Sci., 120, 385-393.
40. Merle,P. et al. (2004) Functional consequences of frizzled-7 receptor over-expression in human hepatocellular carcinoma. Gastroenterology, 127, 1110-1122.
41. Westfall,T.A. et al. (2003) Wnt-5/pipetail functions in vertebrate axis formation as a negative regulator of Wnt/beta-catenin activity. J. Cell Biol., 162, 889-898.
42. Topol,L. et al. (2003) Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J. Cell Biol., 162, 899-908.
43. Tamura,M. et al. (1999) PTEN gene and integrin signaling in cancer. J. Natl Cancer Inst., 91, 1820-1828.
44. Berridge,M.J. et al. (1998) Calcium - a life and death signal. Nature, 395, 645-648.
45. Toyota,M. et al. (1999) Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant methylation of its 5′ CpG island in human tumors. Cancer Res., 59, 4535-4541.
46. Yin,Y. et al. (2003) PAC1 phosphatase is a transcription target of p53 in signalling apoptosis and growth suppression. Nature, 422 527-531.
47. Du,J. et al. (2008) Bone morphogenetic protein 6 inhibit stress-induced breast cancer cells apoptosis via both Smad and p38 pathways. J. Cell. Biochem. 103, 1584-1597.